| Clinical translation of silica nanoparticles TI Janjua, Y Cao, C Yu, A Popat Nature Reviews Materials 6 (12), 1072-1074, 2021 | 159 | 2021 |
| Frontiers in the treatment of glioblastoma: Past, present and emerging TI Janjua, P Rewatkar, A Ahmed-Cox, I Saeed, FM Mansfeld, ... Advanced drug delivery reviews 171, 108-138, 2021 | 146 | 2021 |
| Encapsulation and controlled release of resveratrol within functionalized mesoporous silica nanoparticles for prostate cancer therapy Z Chaudhary, S Subramaniam, GM Khan, MM Abeer, Z Qu, T Janjua, ... Frontiers in bioengineering and biotechnology 7, 225, 2019 | 113 | 2019 |
| Facile synthesis of lactoferrin conjugated ultra small large pore silica nanoparticles for the treatment of glioblastoma TI Janjua, A Ahmed-Cox, AK Meka, FM Mansfeld, H Forgham, ... Nanoscale 13 (40), 16909-16922, 2021 | 33 | 2021 |
| Efficient delivery of Temozolomide using ultrasmall large-pore silica nanoparticles for glioblastoma TI Janjua, Y Cao, A Ahmed-Cox, A Raza, M Moniruzzaman, DT Akhter, ... Journal of Controlled Release 357, 161-174, 2023 | 18 | 2023 |
| Silica nanoparticles: A review of their safety and current strategies to overcome biological barriers TI Janjua, Y Cao, F Kleitz, M Linden, C Yu, A Popat Advanced Drug Delivery Reviews, 115115, 2023 | 15 | 2023 |
| Protein Nanoparticles for Enhanced Oral Delivery of Coenzyme-Q10: in Vitro and in Silico Studies VJ Banun, P Rewatkar, Z Chaudhary, Z Qu, T Janjua, A Patil, Y Wu, HT Ta, ... ACS Biomaterials Science & Engineering 9 (6), 2846-2856, 2021 | 12 | 2021 |
| Nanobiomaterials to modulate natural killer cell responses for effective cancer immunotherapy A Raza, GR Rossi, TI Janjua, F Souza-Fonseca-Guimaraes, A Popat Trends in Biotechnology 41 (1), 77-92, 2023 | 10 | 2023 |
| Formulation and biological evaluation of mesoporous silica nanoparticles loaded with combinations of sortase A inhibitors and antimicrobial peptides S Alharthi, ZM Ziora, T Janjua, A Popat, PM Moyle Pharmaceutics 14 (5), 986, 2022 | 9 | 2022 |
| Virus-like silica nanoparticles enhance macromolecule permeation in vivo Y Cao, TI Janjua, Z Qu, B Draphoen, Y Bai, M Linden, M Moniruzzaman, ... Biomaterials Science 11 (13), 4508-4521, 2023 | 6 | 2023 |
| Engineered smart materials for RNA based molecular therapy to treat Glioblastoma RR Singh, I Mondal, T Janjua, A Popat, R Kulshreshtha Bioactive Materials 33, 396-423, 2024 | 4 | 2024 |
| Virus-like silica nanoparticles improve permeability of macromolecules across the blood–brain barrier in vitro Y Feng, Y Cao, Z Qu, TI Janjua, A Popat Pharmaceutics 15 (9), 2239, 2023 | 4 | 2023 |
| Influence of pore size and surface functionalization of mesoporous silica nanoparticles on the solubility and antioxidant activity of confined coenzyme Q10 AK Meka, A Gopalakrishna, C Iriarte-Mesa, P Rewatkar, Z Qu, X Wu, ... Molecular Pharmaceutics 20 (6), 2966-2977, 2023 | 4 | 2023 |
| Cannabidiol-Help and hype in targeting mucosal diseases M Moniruzzaman, TI Janjua, JH Martin, J Begun, A Popat Journal of Controlled Release 365, 530-543, 2024 | 1 | 2024 |
| Silica nanoparticles for brain cancer Y Feng, Y Cao, R Singh, TI Janjua, A Popat Expert Opinion on Drug Delivery 20 (12), 1749-1767, 2023 | | 2023 |
| Nanomedicine for brain cancer J Khan, T Iqbal | | 2023 |
Associate Professor Amirali PopatDirector of Research, School of Pharmacy, The University of Queensland, Associate Editor JCRПідтверджена електронна адреса в uq.edu.au
